FINCH THERAPEUTICS GROUP INC (FNCH) Stock Analyst Ratings
USA - NASDAQ:FNCH - US31773D2009 - Common Stock
1.8 USD
-0.18 (-9.09%)
1.8001 USD
+0 (+0.01%)
ChartMill assigns a Buy % Consensus number of 83% to FNCH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 91.8. This target is 5000% above the current price.
FNCH was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FNCH.
In the previous month the buy percentage consensus was at a similar level.
FNCH was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2022-08-09 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-13 | Evercore ISI Group | Initiate | Outperform |
| 2021-04-13 | B of A Securities | Initiate | Buy |
| 2021-04-13 | Jefferies | Initiate | Buy |
FINCH THERAPEUTICS GROUP INC / FNCH FAQ
Can you provide the average price target for FINCH THERAPEUTICS GROUP INC stock?
7 analysts have analysed FNCH and the average price target is 91.8 USD. This implies a price increase of 5000% is expected in the next year compared to the current price of 1.8.
How do analysts rate FINCH THERAPEUTICS GROUP INC (FNCH)?
The consensus rating for FINCH THERAPEUTICS GROUP INC (FNCH) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover FINCH THERAPEUTICS GROUP INC (FNCH) stock?
The number of analysts covering FINCH THERAPEUTICS GROUP INC (FNCH) is 7.